36 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday.
iQIYI Registers Flat Revenue Growth In Q4; Targets Non-GAAP Operating Break-Even For FY22
iQIYI Inc (NASDAQ:IQ) reported fourth-quarter FY21 revenue of $1.2 billion, flat year-on-year, beating the consensus of $1.15 billion. Segments: Membership services…
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 34 stocks hit new 52-week lows.
OTR Global Downgrades iQIYI to Negative
OTR Global downgrades iQIYI (NASDAQ:IQ) from Mixed to Negative.
63 Biggest Movers From Yesterday
Gainers
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors.
44 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors.
Mid-Day Market Update: Crude Oil Rises 0.5%; Integrated Media Technology Shares Jump
Midway through trading Thursday, the Dow traded up 0.04% to 36,504.54 while the NASDAQ rose 0.59% to 15,859.87. The S&P also rose, gaining 0.14% to 4,799.86.
Benchmark Initiates Coverage On iQIYI with Hold Rating
Benchmark analyst Fawne Jiang initiates coverage on iQIYI (NASDAQ:IQ) with a Hold rating.